Lindus Health · Series B

The anti-CRO running radically faster, AI-enabled clinical trials end to end

Amount

$55M

Round

Series B

Valuation

—

Announced

—

Investors

Participating investors

Seedcamp Balderton Capital Creandum Visionaries Club firstminute capital